GSTM1 and colorectal carcinoma: It has previously been demonstrated that f-Hb assessed by FIT is strongly correlated to CRC risk, with recent meta-analyses reporting the sensitivity of FIT for CRC in symptomatic patients between 92 per cent and 94 per cent25,26, therefore can be useful in the triage of referred patients with abdominal symptoms16,27.